China's WeDoctor offers free coronavirus consultations globally in English and Chinese

Image: Shutterstock

WeDoctor lets anyone in the world send queries to doctors who fought to save lives in China’s most affected Covid-19 districts, and now helping people overseas to stay safe during the pandemic

After a grueling two-month campaign to stop the spread of Covid-19, China has finally hit the milestone of “zero” new domestic cases. In a bid to help other countries tackle the surge in coronavirus infections, China is now pro-actively sending resources and medical aid overseas. Healthcare platforms like Hangzhou-based WeDoctor is amongst the first to receive support to expand its services abroad, with support from the China International Exchange and Promotion Association for Medical and Healthcare.On March 14, WeDoctor launched its English/Chinese language platform, WeDoctor Global Consulta...
Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading

Edited by Suzanne Soh, Wang Xiao'e

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.